Obesity: mediators and treatment approaches.
Bloomgarden
Zachary T
ZT
D000682:Amyloid / Q000627:therapeutic use; D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D001066:Appetite; D050110:Bariatric Surgery; D048909:Diabetes Complications / Q000503:physiopathology; D003920:Diabetes Mellitus / Q000178:diet therapy / Q000503:physiopathology*; D050528:Diet, Carbohydrate-Restricted; D005234:Fatty Liver / Q000473:pathology; D005260:Female; D005746:Gastric Emptying / Q000187:drug effects; D006801:Humans; D007328:Insulin / Q000502:physiology; D058228:Islet Amyloid Polypeptide; D008066:Lipolysis / Q000502:physiology; D008297:Male; D009478:Neuropeptide Y / Q000502:physiology; D009765:Obesity / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology* / Q000601:surgery
D000682:Amyloid; D019440:Anti-Obesity Agents; D007328:Insulin; D058228:Islet Amyloid Polypeptide; D009478:Neuropeptide Y; C105254:pramlintide